Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Ronald Campbell Loucks Insider Profile
4 Followers
Ronald Campbell Loucks, President & Chief Executive Officer, Ten Percent Owner at NexgenRx, holds 7.46M shares in NexgenRx (Ticker: TSE:NXG). Most recently, Ronald Campbell Loucks Bought C$120,000 shares of NexgenRx on May 28, 2024 for an estimated value of 33.60K.
Ronald Campbell Loucks NexgenRx (NXG)President & Chief Executive Officer, Ten Percent Owner
NexgenRx (NXG)
President & Chief Executive Officer, Ten Percent Owner
Ranked #9,972 out of 99,635 Corporate Insiders
Profitable Transactions
6 out of 7 Profitable Transactions
Average Return
+23.70%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Ronald Campbell Loucks's holdings
Insider Roles
President & Chief Executive Officer, Ten Percent Owner
Roles that Ronald Campbell Loucks holds in companies
Most Profitable Insider Trade
The most profitable trade made by Ronald Campbell Loucks
Ronald Campbell Loucks's Trading History
List of latest transactions for each holding click on a transaction to see Ronald Campbell Loucks's performance on stock
You May Also Like
Ronald Campbell Loucks insider profile FAQ
What is the percentage of profitable transactions made by Ronald Campbell Loucks?
The percentage of profitable transactions made by Ronald Campbell Loucks is 86%.
What is the average return per transaction made by Ronald Campbell Loucks?
The average return per transaction made by Ronald Campbell Loucks is 23.70%.
What stocks does Ronald Campbell Loucks hold?
Ronald Campbell Loucks holds: TSE:NXG stocks.
What was Ronald Campbell Loucks’s latest transaction?
Ronald Campbell Loucks latest transaction was an Informative Buy of C$33.60K.
What was Ronald Campbell Loucks's most profitable transaction?
Ronald Campbell Loucks’s most profitable transaction was an Informative Buy of TSE:NXG stock on July 10, 2020. The return on the trade was 81.60%.
What is Ronald Campbell Loucks's role in NexgenRx?
Ronald Campbell Loucks's role in NexgenRx is President & Chief Executive Officer, Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.